SNTI
Senti Biosciences Holdings, Inc.
Nasdaq Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Net Income
$-61438000
↓ 16.4%
Operating Income
$-68779000
↓ 12.7%
Revenue
$22000
↑ Infinity%
EPS (Diluted)
$-2.73
↑ 77.3%
Total Assets
$51.2M
↓ 47.6%
Total Liabilities
$45.6M
↓ 3.1%
Shareholders' Equity
$5.6M
↓ 78.2%
Cash & Equivalents
$16.4M
↓ 66.0%

Recent SEC Filings

Form Type Filed Date Link
EFFECT 9/24/2026 View on SEC
DEFM14A 9/24/2026 View on SEC
424B3 9/24/2026 View on SEC
8-K 9/24/2026 View on SEC
PRER14A 9/24/2026 View on SEC
S-3/A 9/22/2026 View on SEC
SCHEDULE 13D/A 9/11/2026 View on SEC
S-3/A 9/10/2026 View on SEC
PRER14A 9/4/2026 View on SEC
DEFA14A 9/4/2026 View on SEC

Company Information

Field Value
Ticker SNTI
Company Name Senti Biosciences Holdings, Inc.
CIK 1854270
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (650) 239-2030